Domenico Ribatti
University of Bari
965 Papers
6.1K Citations
Domenico Ribatti is an academic researcher from University of Bari. The author has contributed to research in topics: Angiogenesis & Biology. The author has an hindex of 96, co-authored 913 publications. Previous affiliations of Domenico Ribatti include University of Genoa & National Institutes of Health.
Chat about Author
Papers
Mast cells in rheumatoid arthritis.
TL;DR: Mast cells are involved in angiogenesis during RA, and their proteolytic activity results in cartilage destruction and bone remodeling, and could be a target in the treatment of RA.
In vitro and in vivo proposal of an artificial esophagus.
M. Marzaro,Simonetta Vigolo,Barbara Oselladore,Maria Teresa Conconi,Domenico Ribatti,Stefano Giuliani,Beatrice Nico,G. Perrino,Gastone G. Nussdorfer,Pier Paolo Parnigotto +9 more
TL;DR: Results suggest that patches composed of homologous esophageal acellular matrix and autologous SMCs may represent a promising tissue-engineering approach for the repair of esophages injuries.
Desmin-positive pericytes in the chick embryo chorioallantoic membrane in response to fibroblast growth factor-2.
Beatrice Nico,Maria Grazia Ennas,Enrico Crivellato,Annalisa Frontino,Domenica Mangieri,Michela De Giorgis,Luisa Roncali,Domenico Ribatti +7 more
TL;DR: Analysis of pattern of distribution of desmin in chick embryo chorioallantoic membrane (CAM) vasculature in normal condition and in response to an angiogenic cytokine, such as fibroblast growth factor-2 (FGF-2) is analyzed by using conventional immunohistochemistry and confocal laser scanning microscopy.
Zoledronic acid affects over-angiogenic phenotype of endothelial cells in patients with multiple myeloma.
Claudio Scavelli,Giulia Di Pietro,Teresa Cirulli,Mauro Coluccia,Angela Boccarelli,Teresa Giannini,Giuseppe Mangialardi,Raffaello Bertieri,Addolorata Coluccia,Domenico Ribatti,Franco Dammacco,Angelo Vacca +11 more
TL;DR: The results provide evidence of a direct antiangiogenic activity of zoledronic acid on multiple myeloma patient-derived endothelial cells due to at least four different mechanisms identified either in vitro or in vivo.
Endothelial cells in the bone marrow of patients with multiple myeloma
Angelo Vacca,Roberto Ria,Fabrizio Semeraro,Francesca Merchionne,Mauro Coluccia,Angela Boccarelli,Claudio Scavelli,Beatrice Nico,Angela Gernone,Feliciana Battelli,Antonio Tabilio,Diego Guidolin,Maria Teresa Petrucci,Domenico Ribatti,Franco Dammacco +14 more
TL;DR: A mixture (or a sequence) of antiangiogenic agents coupled with thalidomide would seem plausible for the biologic management of active multiple myeloma.